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Abstract
This paper reports findings from Germany-based participants in the “Your DNA, Your Say” study, a collaborative effort
among researchers in more than 20 countries across the world to explore public attitudes, values and opinions towards
willingness to donate genomic and other personal data for use by others. Based on a representative sample of German
residents (n= 1506) who completed the German-language version of the survey, we found that views of genetic
exceptionalism were less prevalent in the German-language arm of the study than in the English-language arm (43% versus
52%). Also, people’s willingness to make their data available for research was lower in the German than in the English-
language samples of the study (56% versus 67%). In the German sample, those who were more familiar with genetics, and
those holding views of genetic exceptionalism were more likely to be willing to donate data than others. We explain these
findings with reference to the important role that the “right of informational self-determination” plays in German public
discourse. Rather than being a particularly strict interpretation of privacy in the sense of a right to be left alone, the German
understanding of informational self-determination bestows on each citizen the responsibility to carefully consider how their
personal data should be used to protect important rights and to serve the public good.
Introduction
Biomedical research and practice are becoming increasingly
data driven. Reasons for this lie both in the demand and in
the supply side. On the demand side, the idea that medicine
and healthcare should be “personalised” in the sense that
prevention, diagnosis, and treatment should be tailored to
the individual characteristics of people, means that more
data from people are needed. This includes both genomic
and other molecular data, biophysical data, and most
recently also increasing volumes of behavioural data that is
seen to characterise people’s “lifestyle”. On the supply side,
ever wider aspects of people’s bodies and lives are “data-
fied”—that is, they are captured in digital data, via portable
or wearable sensors [1]. This means that increasingly large
and varied data sets are available that could, in principle,
be utilised for medical practice and research.
The mere availability of these data, of course, does not
guarantee its quality or utility. Recent scholarship has
emphasised the labour and resources needed to make data
discoverable, intelligible, and interoperable [2, 3]. Scho-
lars have also warned that “big data won’t cure us” [4].
The fact, however, that these data are available creates
pressure to use them to improve individual and/or public
health [5].
Besides the urgency to improve the interoperability,
interpretation, and utility of this data, this development
raises manifold questions as to how to share and govern the
use of these data, and for whose benefit. There is a wide
agreement among scholars that regulation of genomic and
medical data sharing should be informed, in some way, by
how people would like their data and information to be
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used. Producing such empirical evidence on people’s views
and preferences is the purpose of the “Your DNA, Your
Say” (YDYS) study, a collaborative large-scale survey that
is currently available in 14 languages. First results from the
English-language survey have been published [6, 7].
Respondents to the English-language arm were based in
four countries: the United Kingdom, the United States,
Canada, and Australia.
In this article, we report findings from respondents to the
German-language version of the survey who resided in
Germany at the time of their participation. The German-
language branch of the study is led by the first and last
author of this paper (THV and BP). Germany is an inter-
esting case in terms of public attitudes towards medical and
genetic innovations and the willingness to donate and share
medical and genomic data. In the past, it had been shown
that the German public tends to be rather sceptical towards
genetic testing [8–10]. More recently though, studies found
that Germans are open to the broad use of medical data and
data sharing [11–13]. In light of these ambivalent findings,
it is important to learn more about peoples’ willingness to
donate medical and genomic data, to share it with doctors
and allow for it to be used for research by non-profit and
for-profit organisations.
Methods
Survey development
The survey was developed by the Participant Values Task
Team (PVTT) from the Global Alliance for Genomics and
Health, an international group of researchers (both non-
profit and for-profit), policy makers, clinicians, and patient
representatives, all with expertise in scientific, legal or
social aspects of clinical, and/or research genomics. Survey
items were primarily designed by Anna Middleton, Heidi
Howard, and Emilia Niemiec, with input from the PVTT
(for details see Ref. [14]).
The first and senior author on this paper, who are both
fully fluent in English and German, translated the English
survey into German. They did this by initially translating
the survey from English to German independently and then
comparing the translations and discussing all instances
where there were discrepancies between the two transla-
tions. The German text was subsequently back translated to
English by these authors and a number of volunteers to
identify further possible ambiguities and inconsistencies,
upon which further adjustments were made. About a dozen
bilingual colleagues—some of whom were familiar with
the YDYS project while others were not—read and com-
mented on various drafts of the translation before it was
finalised.
Sample
Using a market research company, Dynata1, we collected
completed surveys from a representative sample of indivi-
duals in Germany (n= 1506). Dynata adheres to the ESO-
MAR market research code of conduct and is able to recruit
participants from nationally representative research panels
from across the world. Participants were paid a small
financial reward (<€1) for participating. In total, 4391 par-
ticipants started the survey with 1506 completing it, which
is a completion rate of 34.3%. Dynata did not provide
information on how many people they invited to take the
survey. Where sections of the population were under-
represented, Dynata contacted additional respondents to
more closely approximate population data. All participants
whose data were analysed for this paper filled in the survey
between 19 August and 3 September 2017.
Measures
Our online survey consists of 29 questions, all of which
have multiple choice answers and some of these also have
an additional request to elaborate in free text. Questions and
answers are the same as the English-language version. Data
from log files show that it took respondents an average of
35 min to complete the survey. The full survey can be
accessed at www.YourDNAYourSay.org. Detailed infor-
mation on the survey, including the survey design, the short
videos that precede different sets of questions and explain
basic concepts of genomics and data sharing in non-
technical terms, the methodology as well as data storage,
protection and privacy and a discussion of some limitations
of the survey can be found in a separate article [14, 15].
Statistical analysis
Sample characteristics were analysed using standard
descriptive statistics. Multivariate correlation analyses were
used to study effects between different variables, most
notably to investigate the association between the will-
ingness to donate DNA for research by different entities
and: (1) the personal perception of the status of genetic
information (genetic exceptionalism); (2) familiarity with
genetics; (3) perspective on harms associated with linking
DNA to other personal information. Age, gender, marital
status, having children, education level, and religiosity were
included as covariates.
We only ran statistical analyses for the German sample,
which this paper focuses on. In case of comparison with the
English language sample, we used the statistical results
1 At the time when the survey was conducted the same company
operated under the brand name ResearchNow (https://www.dynata.com)
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published in the respective articles and provide references to
those data sets and statistics.
Results
Sample description
Regarding age, gender, and education, the distribution in
the sample (n= 1506) resembles the general population in
Germany according to the 2011 census (Table 1). For his-
torical reasons, race or ethnicity is not included in the
German census. In our sample, 93% of participants
identified as white. Because of the low absolute numbers
(n= 56) of respondents who identified as non-whites in our
sample, we did not use race or ethnicity as a variable for the
analysis.
Genetic exceptionalist views and familiarity with
genetics
Less than half of our respondents held views of genetic
exceptionalism (~43%). Genetic exceptionalism refers to
the idea that genetic material and genetic information are
considered as categorically different from other types of
information and as such may require additional and/or
Table 1 Sample characteristics by perspective on seeing DNA information as the same/unsure or different to medical information (‘genetic
exceptionalist’ views) (N indicates count; % indicates percentage).
Variable Categories Total
(n= 1506)
Willing
(n= 844)
Unwilling
(n= 257)
Unsure
(n= 405)
p
N % N % N % N %
Genetic
exceptionalist views
No 865 57.44 438 50.64 164 18.96 263 30.40 <0.0001
Yes 641 42.56 406 63.34 93 14.51 142 22.15
Genetic knowledge Unfamiliar 1066 70.78 533 50.00 195 18.29 338 31.71 <0.0001
Familiar 439 29.15 310 70.62 62 14.12 67 15.26
Missing 1 0.07 1 100 0 0 0 0
Age 30 and under 379 25.17 250 65.96 48 12.66 81 21.37 <0.0001
31–40 239 15.87 129 53.97 38 15.90 72 30.13
41–50 282 18.73 137 48.58 51 18.09 94 33.33
51–60 264 17.53 148 56.06 43 16.29 73 27.65
Over 60 342 22.71 180 52.63 77 22.51 85 24.85
Missing 0 0 0 0 0 0 0 0
Gender Female 764 50.73 417 54.58 126 16.49 221 28.93 0.052
Male 731 48.54 423 57.87 126 17.24 182 24.90
Prefer not to say 11 0.73 4 36.36 5 45.45 2 18.18
Missing 0 0 0 0 0 0 0 0
Children No 704 46.75 400 56.82 123 17.47 181 25.71 0.090
Yes 781 51.86 438 56.08 127 16.26 216 27.66
Prefer not to say 21 1.39 6 28.57 7 33.33 8 38.10
Missing 0 0 0 0 0 0 0 0
Education Tertiary 462 30.68 284 61.47 82 17.75 96 20.78 0.002
Secondary 820 54.45 451 55.00 128 15.61 241 29.39
Primary or less 224 14.87 109 48.66 47 20.98 68 30.36
Missing 0 0 0 0 0 0 0 0
Religiosity Not a
religious person
967 64.21 526 54.40 182 18.82 259 26.78 0.045
A religious person 538 35.72 318 59.11 75 13.94 145 26.95
Missing 1 0.07 0 0 0 0 1 100
Relationship Married/civil
partnership/living
together
869 57.71 485 55.81 155 17.84 228 26.35 0.186
Divorced/single/
widowed
636 42.22 359 56.45 102 16.04 175 27.52
Missing 1 0.07 0 0 0 0 1 100
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special governance measures (e.g., specific laws for genetic
data). For the purpose of this publication we considered the
answer “For me, DNA information is different to other
medical information” as indicating a genetic exceptionalism
view. In the German language sample, this number is ten
percentage points lower than among participants in the
English-language survey, where over half (52%) of YDYS
survey participants subscribed to genetic exceptionalism.
Participants had the option to give free text answers on their
reasons as to why they consider genetic information
exceptional. The three most common reasons were that “it is
unique”, it is “the most personal data we have”, and “it
clearly only belongs to yourself”. In terms of socio-
demographic variables, there was very little variation
between those who did and did not hold genetic excep-
tionalist views. Respondents who held genetic exception-
alist views were more likely to be under the age of 30 (this
age group made up 29% of people with genetic excep-
tionalist views versus 25% in the overall sample) and more
likely to have tertiary education (34% versus 31%).
About a third of our participants stated that they were
familiar with DNA, genetics, or genomics. Familiarity with
DNA, genetics or genomics refers to more than just
knowing about DNA but actual experience: “Yes, I’m
familiar through my work, personal interests or family/
medical history”. The three most frequently reported sour-
ces for familiarity about genetics were personal interest in
ancestry and genealogy websites (~33%), personal or family
related experiences due to a genetic condition (~11%), and
familiarity obtained through professional experience outside
of the field of genetics (~10%). In contrast to the topic of
genetic exceptionalism, where sociodemographic factors
did not correlate with specific views, we found that parti-
cipants who reported previous familiarity with genetics
were more likely to: have a university degree (45.9% versus
30.7% in the overall sample), hold views of genetic
exceptionalism (52.7% versus 42.6); have no children
(50.7% versus 46.8%); be religious (39.8% versus 35.7%)
and be under the age of 30 (37.9% versus 25.2%) (Table 2).
Sensitivity towards different types of personal data
When asked whether all personal data—such as holiday
photos, bank information, and medical and DNA informa-
tion—should have the same level of protection, or whether
any data type deserved special protection, 58% of our
respondents said that they should all be treated the same. A
much smaller proportion (34%) said that these types of
information deserve different levels of protection (without
yet specifying which types of information deserved more,
and which ones less protection), and 8% of participants
were not sure. When those who said that different data types
deserved different levels of protection were asked to rank
these data types according to how much protection they
deserved, banking information was ranked highest (76%)
with medical and DNA information coming second (both
were ranked highest by 67% of respondents). Holiday
photos were considered least sensitive (13%).
Willingness to donate medical and genetic data
A bit more than half (56%) of our respondents were willing
to donate medical and DNA information, either to medical
doctors or to (non- or for-profit) research. Participants were
classified as willing to donate if they said they would agree
to make their data available to at least one of the three
groups: medical doctors, non-profit researchers, or for-profit
researchers. This proportion is lower than in the English
speaking countries where more than 67% were willing to
donate their medical and DNA information in at least one
scenario [6].
Table 2 Sample characteristics by being familiar or unfamiliar with
genetics (N indicates count; % indicates percentage).
Variable Category Familiar Unfamiliar
N % N %
Genetic
exceptionalist views
Yes 232 52.73 409 38.37
No 208 47.27 657 61.63
Relationship Married/civil
partnership/
living together
250 56.82 619 58.12
Divorced/
Single/
Widowed
190 43.18 446 41.88
Willingness to donate Yes 311 70.68 533 50.00
No 62 14.09 195 18.29
Not Sure 67 15.23 338 31.71
Gender Female 217 49.32 547 51.31
Male 216 49.09 515 48.31
Prefer not to say 7 1.59 4 0.38
Children Yes 211 47.95 570 53.47
No 223 50.68 481 45.12
Prefer not to say 6 1.36 15 1.41
Education Tertiary 202 45.91 260 24.39
Secondary 207 47.05 613 57.50
Primary or less 31 7.05 193 18.11
Ethnicity White 398 93.65 1009 97.49
Non-White 27 6.35 26 2.51
Religiosity Yes 175 39.77 363 34.05
No 265 60.23 702 65.85
Age Under 30 167 37.96 212 19.89
30–60 197 44.77 588 55.16
60 and over 76 17.27 266 24.95
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When asked whether they would donate their DNA and
medical information for use by medical doctors, almost half
of our respondents (48%) said they would; about one
quarter (25%) said they would not, and 28% said they were
unsure (Table 3). The proportions were roughly similar
in response to the question of whether they would donate
their DNA and medical information for use by non-profit
researchers, with slightly fewer (42%) giving a straightfor-
wardly positive answer and slightly more saying no (28%;
29% said they were unsure). Our respondents were con-
siderably less willing to make their DNA and medical
information available to for-profit researchers: less than a
quarter (23%) were willing to do so, while almost half
(48%) were not, and 29% said they were unsure. Those who
were unsure whether or not to donate their medical or DNA
information made no distinction between the potential user
group. Those who were willing to donate clearly dis-
tinguished between medical doctors and non-profit research
on the one hand, and for-profit research on the other, with a
clear preference to donate to the former two.
We investigated the possible influences on people’s
willingness to donate and we found two main factors. First,
there was variation between those who held genetic
exceptionalist views and those who did not. Second, pre-
vious familiarity with genetics had a moderating effect on
willingness to donate. Participants with genetic exception-
alist views were overall slightly more likely to donate DNA
and medical data (63% versus 56%). This difference was
observed for all three domains with 55% versus 48% for
medical doctors, 50% versus 42% for non-profit, and 28%
versus 23% for for-profit research. In line with the overall
sample, willingness to donate was the lowest for for-profit
research. In contrast, participants who did not hold genetic
exceptionalist views were significantly less likely to be
willing to donate their medical information, with only 19%
willing to donate their DNA and medical information for
for-profit research (Table 3).
Similar effects could be observed for participants who
considered themselves familiar with genetics. Overall, they
were significantly more willing than others to donate DNA
and medical information (71%). Their willingness to donate
to medical doctors and for non-profit was also very high at
58% and 56%, respectively. Most notably, 35% of partici-
pants with previous genetic familiarity were also willing to
donate their information to for-profit research. Thus, pre-
vious genetic familiarity had an even stronger effect than
genetic exceptionalist views on willingness to donate
medical information.
Multivariate analysis of attitudes towards donation
In our multivariable analysis, we used a multinomial
logistic regression model to analyse the determinants on
willingness to donate. We included the following variables
as covariates with possible influencing effects: genetic
exceptionalist views, familiarity with genetics, age, gender,
having children, education level, and religiosity (Table 4).
Participants who were unwilling or unsure about donat-
ing their medical and DNA information were less likely to
express genetic exceptionalist views (odds ratio (OR) 0.71;
95% confidence interval (CI) 0.52–0.96; p= 0.026 for
unwilling and OR 0.71; CI 0.55–0.91; p= 0.008 for
unsure). In addition, those who were unwilling were less
likely to be familiar with genetics (OR 0.63; CI 0.45–0.89;
p= 0.01). Participants who were unsure about donating
their information were also less likely to be familiar with
genetics (OR 0.41; CI 0.29–0.56; p < 0.001). We found
substantive differences regarding the willingness to donate
across reported age groups. Those who were unwilling or
unsure about donating had lower odds of being 30 years or
younger (OR 0.61; CI 0.40–0.92; p= 0.020 for unwilling
and OR 0.66; CI 0.47–0.94; p= 0.020 for unsure) than
those who were willing to do so. Furthermore, we found
some sociodemographic differences between those who
were willing to donate and those who were unwilling.
Participants who were unwilling to donate their medical and
DNA information showed lower odds in terms of having
children (OR 0.71; CI 0.51–0.99; p= 0.043) than those who
were willing to do so. Compared with those who were
willing to donate, those who were unwilling had also lower
odds of being religious (OR 0.73; CI 0.53–1.00; p= 0.051).
For those who were unsure about donating we found no
significant associations with any sociodemographic data.
In summary, those who were unwilling or unsure about
donating their information were significantly less likely to
view DNA data and medical data as being different to have
gathered genetic familiarity so far and be under the age of
30 than those who were willing to donate. In addition,
those unwilling to donate seem to be less likely to have
children and to be religious than those who were willing to
donate.
Discussion
Three findings from the German sample are particularly
striking and merit further discussion: first, that German
participants were on average less willing to make their data
available for research than participants in the English-
language survey; second, that within the German sample,
those who were more familiar with genetics, and those who
held genetic exceptionalist views, were more willing to
donate their data; and third, that those who held genetic
exceptionalist views tended to be more educated and
younger than the rest of the sample. We will now consider
each of these groups in turn.
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Lower willingness to donate in the German than in
the English-language sample
As noted, 56% of the respondents in the German sample
were willing to donate medical and DNA information to
medical doctors, or to (non- or for-profit) research, com-
pared with over 67% of respondents to the English-
language survey [6]. The survey data do not give us any
insights into the reasons for the lower levels of willingness
to make their DNA and medical information available for
research. We hypothesise that lower willingness to share
data with institutions may be related to the particular pro-
minence of data protection and privacy in public discourses
in Germany.
In a 2010 Eurobarometer survey, which included ques-
tions about biobanks and data privacy, German respondents
articulated the highest level of concern about the protection
of their genetic data of all EU countries [10]. The question
was included in the Eurobarometer special Report [16].
Since then, one more Eurobarometer, published in 2015,
addressed a similar topic, namely data protection [17]. In
that survey, German respondents held very sceptical views.
Because the survey did not include questions on genetic
information specifically, it is not possible to compare atti-
tudes over time.
The high level of concern with regards to sharing med-
ical and genomic information, as well as data privacy may
relate to the specific understanding of informational self-
determination in Germany, which is not only considered a
fundamental right of citizens, but it entails the idea that the
strict protection of personal data “is essential for a free and
self-determined development of the individual […]. If citi-
zens cannot oversee and control […] what kind of infor-
mation about them is openly accessible in their social
environment, and if they cannot even appraise the knowl-
edge of possible communication partners, they may be
inhibited in making use of their freedom” [18]. Also, the
German Genetic Diagnosis Act (Gendiagnostikgesetz,
GenDG), which entered into force on 1 February 2010,
shows a strong focus on the right to informational self-
determination. The right to “informational self-determina-
tion” is grounded in Art. 2 (1) and Art. 1 (1) of the German
Constitution (Grundgesetz), which protect the personal
sphere of life, guaranteeing the respect of human dignity,
and the right of free development of one’s personality. The
concept of informational self-determination was introduced
by the German Federal Constitutional Court (Bundesver-
fassungsgericht) in a ruling relating to personal information.
In its decision on 15th December 1983 it held that “[…] in
the context of modern data processing, the protection of the
individual against unlimited collection, storage, use and
disclosure of his/her personal data is encompassed by the
general personal rights of the Basic Constitutional Law.
This basic right warrants in this respect the capacity of the
individual to determine in principle the disclosure and use
of his/her personal data. Limitations to this informational
self-determination are allowed only in case of overriding
public interest”. The Court held that every citizen has a right
to control the flux of all information relating to him or her. It
also reasoned that the present and future conditions of data
Table 4 Multivariate analysis of attitudes towards donation.
Variable Category Unwilling Unsure
OR LCI UCI p OR LCI UCI p
Genetic exceptionalist views No Ref. Ref.
Yes 0.71 0.52 0.96 0.026 0.71 0.55 0.91 0.008
Genetic knowledge Unfamiliar Ref. Ref.
Familiar 0.634 0.45 0.89 0.010 0.41 0.29 0.56 0.000
Age 30 years and under 0.61 0.40 0.92 0.020 0.66 0.47 0.94 0.020
30–60 years Ref. Ref.
60 years and older 1.38 0.96 1.97 0.075 0.79 0.57 1.09 0.152
Gender Female Ref. Ref.
Male 0.94 0.70 1.26 0.682 0.81 0.63 1.04 0.098
Children No Ref. Ref.
Yes 0.71 0.51 0.99 0.043 0.95 0.71 1.25 0.702
Tertiary education No Ref. Ref.
Yes 1.01 0.73 1.40 0.93 0.77 0.57 1.03 0.084
Religious No Ref. Ref.
Yes 0.73 0.53 1.00 0.051 1.02 0.78 1.32 0.894
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processing and collection permit a wide variety of possible
abuses against which the individual has to be protected [19].
Interpreted in this light, the greater hesitance of German
respondents to make their information available for use by
institutions is not necessarily a sign of distrust in institu-
tions, or a lack of willingness to help others. It could also be
an expression of people’s perceived duty and role as citi-
zens. The latter may also help to explain why there was a
clear preference for making their DNA and medical infor-
mation available to non-profit research in the German
sample (see Table 3), which could be seen as a commitment
to using one’s personal data in such a way that it creates
public benefits. This interpretation is in line with findings
from a qualitative study on NHS England’s care.data pro-
gramme and the reasons as to why people opt out [20].
Participants holding genetic exceptionalist views,
and those who are more familiar with genetics, are
more likely to be willing to make their information
available
We also found that participants who held genetic excep-
tionalist views (63%), and those familiar with genetics
(71%), were more likely to be willing to make their DNA or
medical information available for use by institutions than
the average of the German sample (56%). This is largely in
line with findings from the English-language survey, where
a very similar, higher proportion of those holding genetic
exceptionalist views, and those being familiar with genetics,
were more willing to donate their data, with the greatest
willingness among those who both held genetic excep-
tionalist views and were familiar with genetics [7]. In the
German sample, previous genetic familiarity had an even
stronger effect on people’s willingness to donate than
genetic exceptionalist views.
Also here, we have no indication from the survey data
as to why those who believe that genetic information is
special, and those who consider themselves familiar with
this topic, are more willing to make their information
available than others. Drawing upon the work of collea-
gues exploring this issue in other studies, we think that
the analysis of Hobbs et al. is particularly relevant [9, 10].
In their work with focus groups in Germany and the
United Kingdom, which included biobank participants
and members of “general” publics, these authors found
that both in the German and British sample, the main
reason to participate was the idea that people’s data
“contributed to the ‘common good’, typically presented
by participants as the progress of medical science or
improved population health” [10]. We hypothesise that
also in our sample, the more people felt they understood
the potential of genetics, and the more they felt that
genetic information was “special” in its role to explain
health and disease, the more strongly they felt a duty to
contribute to health research with public benefits.
Familiarity with DNA, genetics and genomics also
increases the willingness to donate medical and genomic
information. This finding is in line with other studies such
as Balck et al. [9]. While they find that Germans are overall
more critical of genetic testing than their comparative
sample of Finnish respondents, they also find that education
is positively correlated with a more positive attitude towards
genetic testing. We think that this is due to the fact that
knowing about details of genetics and genomics helps to
realistically assess opportunities and risks and increases the
willingness to donate personal data.
Genetic exceptionalists were younger and more
educated
The third finding that needs further discussion is that in our
sample, respondents who held genetic exceptionalist views
were slightly overrepresented under the age of 30 and more
likely to have tertiary education (34% versus 31%). The
latter finding—that tertiary education corresponded posi-
tively with the holding of genetic exceptionalist views—
was also present in the larger, English-language sample [7].
A possible explanation for this is that the longer people
have been exposed to science education or training, the
more they are aware of distinctive features of genetic
information, e.g., it is familial and unchangeable. Through
this awareness they believe that genetic information is a
“special” kind of information, which is different to other
personal data. Assuming that many respondents would have
been exposed to science education and training during or
after the Human Genome Project, where public and also
expert discourses focused heavily on the special role and
value of genetic and genomic data, this may have con-
tributed to a greater prevalence of genetic exceptionalist
views among those who were in education and training for
longer.
A correlation that we found in the German sample that
was not found in the English-language survey was the
association between younger age and genetic exceptional-
ism. A possible explanation for the correlation of genetic
exceptionalism and younger age among Germans could be
the current public debate in Germany about the use of
genetic information by the police, which is a debate that
young people in particular participate in [21]. This could
account, in part, for the greater prevalence of genetic
exceptionalism in younger people in Germany. It would be
necessary to conduct further quantitative and qualitative
research in order to substantiate this claim and learn more
about the reasons for this correlation.
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Conclusion
This paper reports from the German arm of the YDYS
study, a research collaboration to explore understandings
and views of publics in many countries and world regions
towards the use of their medical, DNA, and other data. On
the basis of a representative sample of the German popu-
lation, our main findings include that the proportion of those
holding exceptionalist views is lower (43%) than in the
English language part of the survey (52%), and that those
holding exceptionalism views are more likely to be young
and educated. Also, the proportion of those who are willing
to donate their information to research was found to be
considerably lower in the German sample (56%) than in the
English-language arm (67%), with the willingness to donate
to for-profit research being lowest. We also found that those
willing to donate (regardless of the purpose of the research)
tended to be more familiar with genetics, and more likely to
hold views of genetic exceptionalism.
We believe that these findings can best be explained with
reference to the special status that data protection has in
German public discourse. As noted, the right to information
self-determination assumes an important role in German law
and for the identity of many Germans. It is not to be
understood merely as a strong emphasis on privacy in the
sense of a right to be let alone [18]. Instead, it imposes a
positive responsibility on people to think carefully about how
their data should be used, as exercising control over data is
part of one’s autonomy and ultimately also an expression of
citizenship. The expression of autonomy through exercising
one’s right to informational self-determination is not, in turn,
a solipsistic activity where people seek to maximise their
own individual gain; on the contrary, they are expected to
utilise their data in such a way that it protects their own rights
and creates benefits for others or even for the entire
collective.
Against the backdrop of the important role that infor-
mational self-determination plays in German public dis-
course it does make sense that the proportion of people
holding genetic exceptionalist views are relatively low—
because there is great awareness of the need to carefully
control the use of all data types, not only genetic data. The
same perceived responsibility to carefully think about who
one makes her personal data available to could explain the
relatively low willingness to donate data for research in the
German sample. Those with greater familiarity with
genetics, however, and those who believe that genetic data
are “special”, are more aware of the benefits that medical
research can obtain with the help of genetic data specifically
and thus are more willing to donate it.
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